Ramin Of Ebrahimi

Dr. Ramin Of Ebrahimi


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in JACC
Verified
Journal Article
Closed access
RERamin Of Ebrahimi
Ramin Of Ebrahimi
CDCornelius Dyke
Cornelius Dyke
RMRoxana Mehran
Roxana Mehran
SMSteven V. Manoukian
Steven V. Manoukian
FFFrederick Feit
Frederick Feit
GSGregg W. Stone
Gregg W. Stone

20 October 2023 in Science Advances
Verified
Journal Article
Open access
SWShaolei Wang
Shaolei Wang
QCQingyu Cui
Qingyu Cui
PAParinaz Abiri
Parinaz Abiri
MRMehrdad Roustaei
Mehrdad Roustaei
EZEnbo Zhu
Enbo Zhu
THTzung Hsiai
Tzung Hsiai
The current cardiac pacemakers are battery dependent, and the pacing leads are prone to introduce valve damage and infection, plus a complete pacemaker retrieval is needed for battery replacement. Despite the reported wireless bioelectronics to pace the epicardium, open-chest surgery (thoracotomy) is required to implant the device, and the procedure is invasive, requiring prolonged wound healing and health care burden. We hereby demonstrate a fully biocompatible wireless microelectronics with a self-assembled design that can be rolled into a lightweight microtubular pacemaker for intravascular implantation and pacing. The radio frequency was used to transfer energy to the microtubular pacemaker for electrical stimulation. We show that this pacemaker provides effective pacing to restore cardiac contraction from a nonbeating heart and have the capacity to perform overdrive pacing to augment blood circulation in an anesthetized pig model. Thus, this microtubular pacemaker paves the way for the minimally invasive implantation of leadless and battery-free microelectronics.

1 January 2014 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
RERamin Of Ebrahimi
Ramin Of Ebrahimi
FBFaisal G. Bakaeen
Faisal G. Bakaeen
AUAbhimanyu Uberoi
Abhimanyu Uberoi
AAAbbas Ardehali
Abbas Ardehali
JBJanet H. Baltz
Janet H. Baltz
ASA. Laurie Shroyer
A. Laurie Shroyer

2 October 2023 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
RERamin Of Ebrahimi
Ramin Of Ebrahimi
EYElizabeth M. Yano
Elizabeth M. Yano
CACarlos A. Alvarez
Carlos A. Alvarez
PDPaul A. Dennis
Paul A. Dennis
ASA. Laurie Shroyer
A. Laurie Shroyer
JSJennifer A. Sumner
Jennifer A. Sumner
Importance: Cardiovascular disease (CVD) remains the leading cause of death in the US. Women veterans have higher rates of CVD compared with civilian US women; however, analyses of recent trends in mortality from cardiac disease for women veterans are lacking.Objective: To investigate trends in cardiac disease mortality among women veterans over approximately the past 2 decades and compare rates with those for civilian women.Design, Setting, and Participants: In this retrospective longitudinal cohort study, US Veterans Health Administration (VHA) electronic health record data, linked with the National Death Index, were analyzed for CVD trends and rates of cardiac disease mortality among women veterans (aged 18 years or older) with VHA health care encounters from January 1, 2000, to December 31, 2017. These data were compared with a national cohort of civilian women (aged 15 years or older) in the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database, which provides cause-of-death data using death certificates for all US residents. The data analysis was performed between March 10, 2021, and November 28, 2022.Exposure: Cardiac disease mortality among women veterans and civilian women.Main Outcomes and Measures: Cardiac disease mortality was based on International Classification of Diseases, Tenth Revision diagnostic codes (I00-I09, I11, I13, and I20-I51 as defined by CDC WONDER). For women veterans and civilian women, crude and age-adjusted cardiac disease mortality rates (per 100 000 life-years) and 95% CIs were calculated, with the 2000 US general population as the reference for age-adjusted rates.Results: From 2000 to 2017, 817 912 women veterans engaged with VHA health care (mean [SD] age, 45.7 [17.1] years), and 19 022 cardiac disease deaths were identified (22.4% of total deaths). The crude and age-adjusted cardiac disease mortality rates, respectively, per 100 000 life-years were 200.2 (95% CI, 181.0-221.0) and 197.6 (95% CI, 175.2-222.0) in 2000 and 196.0 (95% CI, 186.1-206.4) and 208.1 (95% CI, 196.4-220.4) in 2017, reflecting stable crude rates and a 5.3% increase in age-adjusted rates. For civilian women, the crude and age-adjusted rates decreased over time from 320.7 (95% CI, 319.7-321.8) and 268.1 (95% CI, 267.3-269.0) in 2000 to 220.9 (95% CI, 220.1-221.7) and 164.7 (95% CI, 164.1-165.3) in 2017.Conclusions and Relevance: In this cohort study comparing women veterans and civilian women, cardiac disease mortality rates for women veterans did not exhibit the improvements seen for civilian women during the nearly 2-decade study period. Further research and actionable clinical interventions are warranted to improve cardiovascular care for women veterans, who represent the fastest growing group of patients within the VHA health care system.

28 October 2022 in Current Cardiology Reports
Verified
Journal Article
Closed access
PDF file
AHAnita S. Hargrave
Anita S. Hargrave
JSJennifer A. Sumner
Jennifer A. Sumner
RERamin Of Ebrahimi
Ramin Of Ebrahimi
BCBeth E. Cohen
Beth E. Cohen

30 November 2023 in JACC: Advances
Verified
Journal Article
Open access
RERamin Of Ebrahimi
Ramin Of Ebrahimi
PDPaul A. Dennis
Paul A. Dennis
ASAnnie Laurie W. Shroyer
Annie Laurie W. Shroyer
CTChi-Hong Tseng
Chi-Hong Tseng
CACarlos A. Alvarez
Carlos A. Alvarez
JSJennifer A. Sumner
Jennifer A. Sumner
Post-traumatic stress disorder (PTSD) is associated with increased rates of incident ischemic heart disease (IHD) in women. The purpose of this study was to determine mechanisms of the PTSD-IHD association in women. In this retrospective longitudinal cohort study, data were obtained from electronic health records of all U.S. women veterans who were enrolled in Veterans Health Administration care from January 1, 2000 to December 31, 2017. Propensity score matching was used to match women with PTSD to women without PTSD on age, number of prior Veterans Health Administration visits, and presence of various traditional and nontraditional cardiovascular risk factors at index visit. Cox regression was used to model time until incident IHD diagnosis (ie, coronary artery disease, angina, or myocardial infarction) as a function of PTSD and potential mediating risk factors. Diagnoses of IHD, PTSD, and risk factors were defined by International Classification of Diseases-9th or -10th Revision, and/or Current Procedural Terminology codes. PTSD was associated with elevated rates of developing each risk factor. Traditional risk factors (hypertension, hyperlipidemia, smoking, diabetes) accounted for 24.2% of the PTSD-IHD association, psychiatric risk factors (eg, depression, anxiety, substance use disorders) accounted for 33.8% of the association, and all 13 risk factors accounted for 48.5% of the association. Traditional IHD risk factors explained a quarter of the PTSD-IHD association in women veterans, and over half of the risk of IHD associated with PTSD remained unexplained even when adjusting for a wide range of risk factors. To be actionable, factors underlying the remaining PTSD-IHD association warrant timely investigation.